196 related articles for article (PubMed ID: 26648282)
1. Upregulation of the expression of Wnt5a promotes the proliferation of pancreatic cancer cells in vitro and in a nude mouse model.
Bo H; Gao L; Chen Y; Zhang J; Zhu M
Mol Med Rep; 2016 Feb; 13(2):1163-71. PubMed ID: 26648282
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells.
Bo H; Zhang S; Gao L; Chen Y; Zhang J; Chang X; Zhu M
BMC Cancer; 2013 Oct; 13():496. PubMed ID: 24156409
[TBL] [Abstract][Full Text] [Related]
3. WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer.
Griesmann H; Ripka S; Pralle M; Ellenrieder V; Baumgart S; Buchholz M; Pilarsky C; Aust D; Gress TM; Michl P
Neoplasia; 2013 Jan; 15(1):11-22. PubMed ID: 23359789
[TBL] [Abstract][Full Text] [Related]
4. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway.
Hung TH; Hsu SC; Cheng CY; Choo KB; Tseng CP; Chen TC; Lan YW; Huang TT; Lai HC; Chen CM; Chong KY
Oncotarget; 2014 Dec; 5(23):12273-90. PubMed ID: 25401518
[TBL] [Abstract][Full Text] [Related]
5. WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer.
Ripka S; König A; Buchholz M; Wagner M; Sipos B; Klöppel G; Downward J; Gress T; Michl P
Carcinogenesis; 2007 Jun; 28(6):1178-87. PubMed ID: 17227781
[TBL] [Abstract][Full Text] [Related]
6. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R
Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
[TBL] [Abstract][Full Text] [Related]
7. Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively.
Shojima K; Sato A; Hanaki H; Tsujimoto I; Nakamura M; Hattori K; Sato Y; Dohi K; Hirata M; Yamamoto H; Kikuchi A
Sci Rep; 2015 Jan; 5():8042. PubMed ID: 25622531
[TBL] [Abstract][Full Text] [Related]
8. MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.
Zhou W; Li Y; Gou S; Xiong J; Wu H; Wang C; Yan H; Liu T
Oncotarget; 2015 Nov; 6(35):37557-69. PubMed ID: 26485754
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
[TBL] [Abstract][Full Text] [Related]
10. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.
Schwartz AL; Malgor R; Dickerson E; Weeraratna AT; Slominski A; Wortsman J; Harii N; Kohn AD; Moon RT; Schwartz FL; Goetz DJ; Kohn LD; McCall KD
Clin Cancer Res; 2009 Jun; 15(12):4114-22. PubMed ID: 19470740
[TBL] [Abstract][Full Text] [Related]
11. Wnt/β-Catenin and Wnt5a/Ca Pathways Regulate Proliferation and Apoptosis of Keratinocytes in Psoriasis Lesions.
Zhang Y; Tu C; Zhang D; Zheng Y; Peng Z; Feng Y; Xiao S; Li Z
Cell Physiol Biochem; 2015; 36(5):1890-902. PubMed ID: 26202350
[TBL] [Abstract][Full Text] [Related]
12. WNT5A/JNK signaling regulates pancreatic cancer cells migration by Phosphorylating Paxillin.
Wei W; Li H; Li N; Sun H; Li Q; Shen X
Pancreatology; 2013; 13(4):384-92. PubMed ID: 23890137
[TBL] [Abstract][Full Text] [Related]
13. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.
Xu W; Wang Z; Zhang W; Qian K; Li H; Kong D; Li Y; Tang Y
Cancer Lett; 2015 Jan; 356(2 Pt B):613-27. PubMed ID: 25305448
[TBL] [Abstract][Full Text] [Related]
14. WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells.
Wei W; Sun HH; Li N; Li HY; Li X; Li Q; Shen XH
Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):529-38. PubMed ID: 25308364
[TBL] [Abstract][Full Text] [Related]
15. Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells.
Yamamoto H; Kitadai Y; Yamamoto H; Oue N; Ohdan H; Yasui W; Kikuchi A
Gastroenterology; 2009 Jul; 137(1):242-52, 252.e1-6. PubMed ID: 19582886
[TBL] [Abstract][Full Text] [Related]
16. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
Jin F; Qu X; Fan Q; Wang L; Tang T; Hao Y; Dai K
Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
[TBL] [Abstract][Full Text] [Related]
17. Pim-3 promotes the growth of human pancreatic cancer in the orthotopic nude mouse model through vascular endothelium growth factor.
Wang C; Li HY; Liu B; Huang S; Wu L; Li YY
J Surg Res; 2013 Dec; 185(2):595-604. PubMed ID: 23845873
[TBL] [Abstract][Full Text] [Related]
18. Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition.
Cheng R; Sun B; Liu Z; Zhao X; Qi L; Li Y; Gu Q
J Cell Physiol; 2014 Dec; 229(12):1908-17. PubMed ID: 24464650
[TBL] [Abstract][Full Text] [Related]
19. SphK1 inhibitor SKI II inhibits the proliferation of human hepatoma HepG2 cells via the Wnt5A/β-catenin signaling pathway.
Liu H; Zhang CX; Ma Y; He HW; Wang JP; Shao RG
Life Sci; 2016 Apr; 151():23-29. PubMed ID: 26944438
[TBL] [Abstract][Full Text] [Related]
20. Role of Wnt5a in the proliferation of human glioblastoma cells.
Yu JM; Jun ES; Jung JS; Suh SY; Han JY; Kim JY; Kim KW; Jung JS
Cancer Lett; 2007 Nov; 257(2):172-81. PubMed ID: 17709179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
